Evolent Health(EVH) - 2025 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-K _________________________ (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Registrant's telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: | Class A Common Stock of Evolent Health, Inc., par value $0.01 per share | EVH | New York Stock Exchange | | --- | --- | --- ...